These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25435729)

  • 1. Influence of Xmn 1(G)γ (HBG2 c.-211 C → T) Globin Gene Polymorphism on Phenotype of Thalassemia Patients of North India.
    Kumar R; Kaur A; Agarwal S
    Indian J Hematol Blood Transfus; 2014 Dec; 30(4):286-90. PubMed ID: 25435729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HBG2 -158 (C>T) polymorphism and its contribution to fetal hemoglobin variability in Iraqi Kurds with beta-thalassemia minor.
    Albarawi DJ; Balatay AA; Al-Allawi N
    J Lab Physicians; 2018; 10(4):370-373. PubMed ID: 30498305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the genetic basis of phenotypic heterogeneity in north Indian patients with thalassemia major.
    Sharma N; Das R; Kaur J; Ahluwalia J; Trehan A; Bansal D; Panigrahi I; Marwaha RK
    Eur J Haematol; 2010 Jun; 84(6):531-7. PubMed ID: 20132300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gγ-Xmn I polymorphism: a significant determinant of β-thalassemia treatment without blood transfusion.
    Ansari SH; Shamsi TS; Munzir S; Khan MT; Erum S; Perveen K; Farzana T; Ashraf M; Mehboob T; Moinuddin M
    J Pediatr Hematol Oncol; 2013 May; 35(4):e153-6. PubMed ID: 23389500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High HbF in pregnancy is associated with the Xmn I polymorphism at the -158bp of the G gamma-globin gene.
    Lolis D; Georgiou I; Loizou P; Makrydimas G
    Eur J Obstet Gynecol Reprod Biol; 1995 Jun; 60(2):153-6. PubMed ID: 7543865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-thalassemia intermedia from southern Iran: IVS-II-1 (G-->A) is the prevalent thalassemia intermedia allele.
    Karimi M; Yarmohammadi H; Farjadian S; Zeinali S; Moghaddam Z; Cappellini MD; Giordano PC
    Hemoglobin; 2002 May; 26(2):147-54. PubMed ID: 12144057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hb Knossos (HBB: c.82G > T), β-globin CD 5 (-CT) (HBB: c.17_18delCT) and δ-globin CD 59 (-a) (HBD: c.179delA) mutations in a Syrian patient with β-thalassemia intermedia.
    Moassas F; Nweder MS; Murad H
    BMC Pediatr; 2019 Feb; 19(1):61. PubMed ID: 30777047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of the spectrum of interactions of CAP+1 (A-->C), a silent beta-globin gene mutation, with other beta-thalassemia mutations and globin gene modifiers in north Indians.
    Garewal G; Das R; Awasthi A; Ahluwalia J; Marwaha RK
    Eur J Haematol; 2007 Nov; 79(5):417-21. PubMed ID: 17900295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalassemia Major and Intermedia Patients in East Java do not Show Fetal Hemoglobin Level Difference in Relation to XMNI Polymorphism.
    Wulandari RD; Lyrawati D; Fatchiyah F; Fitri LE
    Med Arch; 2020 Apr; 74(2):90-94. PubMed ID: 32577047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do alpha deletions influence hydroxyurea response in thalassemia intermedia?
    Panigrahi I; Dixit A; Arora S; Kabra M; Mahapatra M; Choudhry VP; Saxena R
    Hematology; 2005 Feb; 10(1):61-3. PubMed ID: 16019448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Xmn I site (-158, C----T) 5' to the G gamma gene: correlation with the Senegalese haplotype and G gamma globin expression.
    Ballas SK; Talacki CA; Adachi K; Schwartz E; Surrey S; Rappaport E
    Hemoglobin; 1991; 15(5):393-405. PubMed ID: 1724976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyurea responses and fetal hemoglobin induction in beta-thalassemia/HbE patients' peripheral blood erythroid cell culture.
    Watanapokasin R; Sanmund D; Winichagoon P; Muta K; Fucharoen S
    Ann Hematol; 2006 Mar; 85(3):164-9. PubMed ID: 16389564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XMN polymorphism along with HU administration renders alterations to RBC membrane lipidome in β-thalassemia patients.
    Khan MBN; Iftikhar F; Ali M; Danish A; Shamsi T; Musharraf SG; Siddiqui AJ
    Chem Phys Lipids; 2022 May; 244():105195. PubMed ID: 35288127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Cis Acting Potential Regulators in the β Globin Gene Cluster on the Production of HbF in Thalassemia Patients.
    Dabke P; Colah R; Ghosh K; Nadkarni A
    Mediterr J Hematol Infect Dis; 2013; 5(1):e2013012. PubMed ID: 23505600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Aγ-globin G->A gene polymorphism associated with β
    Breveglieri G; Bianchi N; Cosenza LC; Gamberini MR; Chiavilli F; Zuccato C; Montagner G; Borgatti M; Lampronti I; Finotti A; Gambari R
    BMC Med Genet; 2017 Aug; 18(1):93. PubMed ID: 28851297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xmn1-G γ polymorphism and clinical predictors of severity of disease in β-thalassemia intermedia.
    Oberoi S; Das R; Panigrahi I; Kaur J; Marwaha RK
    Pediatr Blood Cancer; 2011 Dec; 57(6):1025-8. PubMed ID: 21755589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xmn1-158 γGVariant in B-Thalassemia Intermediate Patients in South-East of Iran.
    Miri-Moghaddam E; Bahrami S; Naderi M; Bazi A; Karimipoor M
    Int J Hematol Oncol Stem Cell Res; 2017 Apr; 11(2):165-171. PubMed ID: 28875012
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
    Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
    Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of XmnIgG Polymorphism in Hydroxyurea Treatment and Fetal Hemoglobin Level at Isfahanian Intermediate β-Thalassemia Patients.
    Motovali-Bashi M; Ghasemi T
    Iran Biomed J; 2015; 19(3):177-82. PubMed ID: 26024726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic heterogeneity and correlation to intergenic haplotype within high HbF beta-thalassemia intermedia.
    Papachatzopoulou A; Kourakli A; Makropoulou P; Kakagianne T; Sgourou A; Papadakis M; Athanassiadou A
    Eur J Haematol; 2006 Apr; 76(4):322-30. PubMed ID: 16519704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.